204 464

Cited 8 times in

Bioactive Compounds for the Treatment of Renal Disease

DC Field Value Language
dc.contributor.author조강수-
dc.date.accessioned2019-02-14T01:50:41Z-
dc.date.available2019-02-14T01:50:41Z-
dc.date.issued2018-
dc.identifier.issn0513-5796-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/167246-
dc.description.abstractKidney diseases including acute kidney injury and chronic kidney disease are among the largest health issues worldwide. Dialysis and kidney transplantation can replace a significant portion of renal function, however these treatments still have limitations. To overcome these shortcomings, a variety of innovative efforts have been introduced, including cell-based therapies. During the past decades, advances have been made in the stem cell and developmental biology, and tissue engineering. As part of such efforts, studies on renal cell therapy and artificial kidney developments have been conducted, and multiple therapeutic interventions have shown promise in the pre-clinical and clinical settings. More recently, therapeutic cell-secreting secretomes have emerged as a potential alternative to cell-based approaches. This approach involves the use of renotropic factors, such as growth factors and cytokines, that are produced by cells and these factors have shown effectiveness in facilitating kidney function recovery. This review focuses on the renotropic functions of bioactive compounds that provide protective and regenerative effects for kidney tissue repair, based on the available data in the literature.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherYonsei University-
dc.relation.isPartOfYONSEI MEDICAL JOURNAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAcute Kidney Injury/pathology-
dc.subject.MESHAcute Kidney Injury/therapy*-
dc.subject.MESHAnimals-
dc.subject.MESHCell Transplantation-
dc.subject.MESHCell- and Tissue-Based Therapy*-
dc.subject.MESHCytokines-
dc.subject.MESHHumans-
dc.subject.MESHIntercellular Signaling Peptides and Proteins-
dc.subject.MESHKidney Diseases/pathology-
dc.subject.MESHKidney Diseases/therapy*-
dc.subject.MESHRegenerative Medicine/methods*-
dc.subject.MESHStem Cell Transplantation-
dc.subject.MESHStem Cells-
dc.subject.MESHTissue Engineering*/methods-
dc.subject.MESHTreatment Outcome-
dc.titleBioactive Compounds for the Treatment of Renal Disease-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Urology (비뇨의학교실)-
dc.contributor.googleauthorKang Su Cho-
dc.contributor.googleauthorIn Kap Ko-
dc.contributor.googleauthorJames J. Yoo-
dc.identifier.doi10.3349/ymj.2018.59.9.1015-
dc.contributor.localIdA03801-
dc.relation.journalcodeJ02813-
dc.identifier.eissn1976-2437-
dc.identifier.pmid30328315-
dc.subject.keywordAcute kidney injury-
dc.subject.keywordchronic-
dc.subject.keywordkidney failure-
dc.subject.keywordregenerative medicine-
dc.subject.keywordtissue engineering-
dc.contributor.alternativeNameCho, Kang Su-
dc.contributor.affiliatedAuthor조강수-
dc.citation.volume59-
dc.citation.number9-
dc.citation.startPage1015-
dc.citation.endPage1025-
dc.identifier.bibliographicCitationYONSEI MEDICAL JOURNAL, Vol.59(9) : 1015-1025, 2018-
dc.identifier.rimsid61451-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.